CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mylan Pharmaceuticals Inc. et al. vs. Pfizer Inc.

Explore the PTAB proceeding IPR2018-01359 filed by Mylan Pharmaceuticals Inc. et al. on 2018-07-06. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2018-01359

Filing Date

2018-07-06

Accorded Filing Date

2018-07-06

Institution Decision Date

2018-10-11

Last Modified Date

2024-01-11

Proceeding Type

IPR

Termination Date

2018-10-11

Trial Status

Terminated

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 15046322
Respondent Patent Number 9566289
Legal Expiration Date
2036-02-17 Active (9.2 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Stephen J. BAKER et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

0 Total

Proceeding Status

Terminated

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Address and Attorney/Agent Information

36 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Pfizer Inc. - Attn:Legal Patent Department, Chief IP Counsel
Customer Number 25291
Address 66 Hudson Boulevard East, New York, NY, 10001-2192, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
34462 Bryan Zielinski +1 858-755-5925
40784 Jeffrey Rennecker +1 858-622-8850
41213 Jeffrey Myers +1 212-733-5061
42640 Suzanne Bates +1 734-622-2658
43080 Lisa Samuels +1 860-686-0349
45051 Chase Romick +1 212-733-8054
46319 Christian Smolizza +1 212-733-9094
48032 John Wichtowski +1 860-715-6645

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 1 proceeding
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2017-11-21
IPR2018-00169

FlatWing Pharmaceuticals, LLC et al. v. Anacor Pharmaceuticals, Inc. et al.

Asserted Patent
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

50
12

Hearing Transcript Paper

2019-03-20 FILING PARTY: BOARD
11

Trial Instituted Document Paper

2018-10-11 FILING PARTY: BOARD
3001

Exhibit Exhibits

2018-10-11 FILING PARTY: BOARD
10

Reply to Opposition to Motion for Joinder Paper

2018-09-06 FILING PARTY: PETITIONER
9

Patent Owner's Motion to Request Acceptance of PTAB E2E Submission Paper

2018-08-13 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc